NOVORIG Trademark

Trademark Overview

On Thursday, August 13, 2020, a trademark application was filed for NOVORIG with the United States Patent and Trademark Office. The USPTO has given the NOVORIG trademark a serial number of 90112581. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, November 12, 2024. This trademark is owned by Rapid Novor Inc.. The NOVORIG trademark is filed in the Chemical Products, Pharmaceutical Products, and Medical & Beauty Services & Agricultural Services categories with the following description:

Medical diagnostic assay kits comprised of medical diagnostic reagents and assays for detecting cancer, autoimmune diseases and infections

Proteomics analysis test kits comprising reagents for detecting, quantifying and characterizing antibody proteins in a biological sample for scientific research purposes

Providing medical diagnostic and prognostic testing for cancer, autoimmune diseases and infections, and the medical analysis, evaluation, and reporting of test results to help healthcare professionals determine a patient's clinical diagnosis, the effectiveness of treatments, and to revise future treatments accordingly; providing medical diagnostic and prognostic testing services; consulting services in the field of medical diagnostic testing; medical analysis services for diagnostic and treatment purposes provided by medical laboratories
novorig

General Information

Serial Number90112581
Word MarkNOVORIG
Filing DateThursday, August 13, 2020
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, November 12, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 12, 2024

Trademark Statements

Goods and ServicesMedical diagnostic assay kits comprised of medical diagnostic reagents and assays for detecting cancer, autoimmune diseases and infections
Goods and ServicesProteomics analysis test kits comprising reagents for detecting, quantifying and characterizing antibody proteins in a biological sample for scientific research purposes
Goods and ServicesProviding medical diagnostic and prognostic testing for cancer, autoimmune diseases and infections, and the medical analysis, evaluation, and reporting of test results to help healthcare professionals determine a patient's clinical diagnosis, the effectiveness of treatments, and to revise future treatments accordingly; providing medical diagnostic and prognostic testing services; consulting services in the field of medical diagnostic testing; medical analysis services for diagnostic and treatment purposes provided by medical laboratories

Classification Information

International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateThursday, September 17, 2020
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, January 1, 0001
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, January 1, 0001
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameRapid Novor Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressKitchener, Ontario N2G4X8
CA
Party NameRapid Novor Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressKitchener, Ontario N2G4X8
CA

Trademark Events

Event DateEvent Description
Thursday, September 17, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, December 8, 2020ASSIGNED TO EXAMINER
Tuesday, December 8, 2020NON-FINAL ACTION WRITTEN
Tuesday, December 8, 2020NON-FINAL ACTION E-MAILED
Tuesday, December 8, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, December 14, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, December 14, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, December 14, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, December 14, 2020TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Monday, December 14, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, December 14, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, December 16, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, March 18, 2021ASSIGNED TO LIE
Tuesday, March 23, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, March 23, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, April 12, 2021ASSIGNED TO EXAMINER
Wednesday, May 5, 2021SUSPENSION LETTER WRITTEN
Wednesday, May 5, 2021LETTER OF SUSPENSION E-MAILED
Wednesday, May 5, 2021NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, November 5, 2021SUSPENSION INQUIRY WRITTEN
Friday, November 5, 2021INQUIRY TO SUSPENSION E-MAILED
Friday, November 5, 2021NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Tuesday, May 3, 2022TEAS REQUEST TO DIVIDE RECEIVED
Tuesday, May 3, 2022DIVISIONAL REQUEST RECEIVED
Tuesday, May 3, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 3, 2022TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Tuesday, May 31, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, May 31, 2022DIVISIONAL PROCESSING COMPLETE
Wednesday, June 1, 2022DATA MODIFICATION COMPLETED
Wednesday, June 1, 2022SUSPENSION LETTER WRITTEN
Wednesday, June 1, 2022LETTER OF SUSPENSION E-MAILED
Wednesday, June 1, 2022NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, December 16, 2022SUSPENSION INQUIRY WRITTEN
Friday, December 16, 2022INQUIRY TO SUSPENSION E-MAILED
Friday, December 16, 2022NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Friday, March 3, 2023TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Friday, March 10, 2023ASSIGNED TO LIE
Monday, March 13, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 13, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 13, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 13, 2023SUSPENSION LETTER WRITTEN
Monday, March 13, 2023LETTER OF SUSPENSION E-MAILED
Monday, March 13, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, October 17, 2023SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Monday, October 23, 2023ASSIGNED TO EXAMINER
Monday, October 23, 2023SUSPENSION INQUIRY WRITTEN
Monday, October 23, 2023INQUIRY TO SUSPENSION E-MAILED
Monday, October 23, 2023NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Wednesday, December 6, 2023TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, December 7, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, December 7, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, December 8, 2023SUSPENSION LETTER WRITTEN
Friday, December 8, 2023LETTER OF SUSPENSION E-MAILED
Friday, December 8, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, August 28, 2024SUSPENSION INQUIRY WRITTEN
Wednesday, August 28, 2024INQUIRY TO SUSPENSION E-MAILED
Wednesday, August 28, 2024NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Friday, September 20, 2024TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Sunday, September 22, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Sunday, September 22, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 1, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 23, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 12, 2024PUBLISHED FOR OPPOSITION
Tuesday, November 12, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Related Keywords

novorig medical diagnostic analysis testing services test treatments providing prognostic infections